UK firm UltraVision CLPL has agreed on a global licensing agreement with Bausch + Lomb for the marketing and sales of KeraSoft contact lens.
UK firm UltraVision CLPL has agreed on a global licensing agreement with Bausch + Lomb for the marketing and sales of KeraSoft contact lens.
The move will enable UltraVision to distribute the lens globally and reach a wider market. Jerry Warner, Vice President of marketing and general manager at Bausch + Lomb, Global Contact Lens, said: "Extending the KeraSoft technology allows the lab to expand the ability of practitioners to offer life-changing vision correction to a wider range of patients who have a variety of irregular cornea conditions resulting from keratoconus and pellucid marginal degeneration."
The custom-made soft lens has been manufactured from silicone hydrogel materials and has been developed to correct irregular corneas, pellucid marginal degeneration and keratoconus.
Joseph Barr, vice president of Global Clinical and Medical Affairs and Professional Services, Vision Care, Bausch + Lomb, said: “This technology has totally transformed my view of contact lens management of keratoconus and irregular cornea patients. The visual results and enhancement of life are true advances.”
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.
AAO 2024: Optimal pupil size reduction percentage for near vision improvement in presbyopia
October 21st 2024Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.